AACR Task Force on Tobacco and Cancer

The AACR Task Force on Tobacco and Cancer was convened in 2009 to foster scientific and policy initiatives to reduce the incidence of disease and mortality due to tobacco use.

Tobacco use is the leading preventable cause of premature mortality, killing more than five million people worldwide every year. It has a particularly profound impact on cancer incidence and mortality. Indeed, tobacco use is causally associated with 18 different cancers, including lung, head and neck, stomach, pancreas, and cervical cancers, and alone tobacco accounts for 30 percent of all cancer deaths.

NEWS:

• Ruling Blocking Graphic Cigarette Health Warnings Presents Major Setback for Public Health (AACR, Nov. 9, 2011)

• AACR Praises New Cigarette Health Warnings as Significant Step Forward; Urges Continued Research to Reduce Tobacco Use (AACR, June 21, 2011)

• Attempts to Weaken FDA Tobacco Regulation Raise Alarm (AACR Cancer Policy Monitor, June 2011)
  

• AACR Draws Congressional Attention to Tobacco Research, Control (AACR Cancer Policy Monitor, April 2011)

• Surgeon General, AACR Leaders Urge Increased Investment in Research to Tackle America’s Tobacco Epidemic (AACR, March 4, 2011)

• New Surgeon General Report on Smoking and Disease Caps Successful Year of Federal Anti-Tobacco Action, AACR Says (AACR, Dec. 9, 2010)

• AACR Applauds Cancer Objectives in Healthy People 2020, Underscores Importance of Federal Funding for Research (AACR, Dec. 3, 2010)

• AACR Praises the U.S. Department of Health and Human Services for its Tobacco Prevention Efforts (AACR, Nov. 10, 2010)

• AACR Recognizes One-year Anniversary of Tobacco Law and the Additional Provisions Taking Effect Today; Calls for More Research to Combat Tobacco Epidemic (AACR, June 22, 2010)

• AACR Releases New Policy Statement on Tobacco and Cancer and Addresses Congressional Panel on Smokeless Tobacco (AACR, April 13, 2010)

• AACR Releases New Statement on Tobacco & Cancer (AACR Cancer Policy Monitor, April 2010)

• AACR Task Force Weighs in on FDA Regulation of Tobacco Products (AACR Cancer Policy Monitor, Oct. 2009)

DOCUMENTS:

• Comments to the U.S. Food and Drug Administration on Cigarette Labeling (January 11, 2011)
  

• Tobacco and Cancer: An American Association for Cancer Research Policy Statement (April 2010)

• Comments to the U.S. Food and Drug Administration (FDA) on the Implementation of the Family Smoking Prevention and Tobacco Control Act (Sept. 29, 2009)

 

TASK FORCE MEMBERS: 

Roy S. Herbst, M.D., Ph.D., Chairperson
Yale Cancer Center
New Haven, Conn.

Los Angeles, Calif.

Thomas H. Brandon, Ph.D.
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Fla.

Denver, Colo.

Michael C. Fiore, M.D., M.P.H., M.B.A.
University of Wisconsin
Madison, Wis.

Pittsburgh, Penn.

Ellen R. Gritz, Ph.D.
The University of Texas M. D. Anderson Cancer Center
Houston, Tex.

Houston, Tex.

Stephen S. Hecht, Ph.D.
University of Minnesota
Minneapolis, Minn.

Scott J. Leischow, Ph.D.
The University of Arizona
Tucson, Ariz.

Caryn Lerman, Ph.D.
University of Pennsylvania
Philadelphia, Penn.

New York, NY

Peter G. Shields, M.D.
Georgetown University Medical Center
Washington, D.C.

David Sidransky, M.D.
Johns Hopkins Medical Institute
Baltimore, Md.

New Haven, Conn.

Kasisomayajula (Vish) Viswanath, Ph.D.
Dana-Farber Cancer Institute
Boston, Mass.

Buffalo, NY

Rockville, Md.

Tampa, Fla.

 

Staff contact:

AACR Office of Science Policy and Government Affairs
Email or call (202) 898-6499

 

Top